Paloma Partners Management CO Edwards Lifesciences Corp Call Options Transaction History

Paloma Partners Management CO

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $2.5 Million - $3.92 Million	41,800 New	41,800 $2.76 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $4.59 Million - $5.78 Million	74,300 New	74,300 $5.67 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $1.6 Million - $1.83 Million	-21,600 Reduced 73.22%	7,900 $653,000
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $969,860 - $1.24 Million	14,200 Added 92.81%	29,500 $2.2 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $675,434 - $879,778	-8,200 Reduced 34.89%	15,300 $1.26 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $2.03 Million - $3.01 Million	23,500 New	23,500 $2.24 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.